Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Paul Poirier
Laval University
484Publications
53H-index
15.4kCitations
Publications 484
Newest
Published on May 10, 2019in Drugs & Aging 2.85
Jacinthe Leclerc1
Estimated H-index: 1
,
Claudia Blais12
Estimated H-index: 12
+ 3 AuthorsPaul Poirier53
Estimated H-index: 53
Background Clopidogrel has been widely used to prevent atherothrombotic events. Since 2011, pharmacists have offered their patients the opportunity to switch to generic clopidogrel, an economic alternative. Whether bioequivalence of generic cardiovascular drugs translates into clinical equivalence at a population level remains unclear and needs to be further documented.
Published in Canadian Journal of Cardiology 5.59
James McKinney5
Estimated H-index: 5
(UBC: University of British Columbia),
Amer M. Johri14
Estimated H-index: 14
(Queen's University)
+ -3 AuthorsKim Connelly (UBC: University of British Columbia)
Abstract Prevention of sudden cardiac arrest/death (SCA/D) among athletes is a universal goal, though the optimal strategy for its achievement is controversial, with the inclusion of the 12-lead electrocardiogram (ECG) at the center of the debate. The ECG exhibits superior sensitivity over history and physical examination to detect conditions associated with SCA/D. However, the identification of disease does not necessarily lead to a significant reduction in SCA/D. The Canadian Cardiovascular So...
Published on Mar 1, 2019in Patient Education and Counseling 2.82
Myriam Gagné2
Estimated H-index: 2
(Laval University),
Claudie Legault (Laval University)+ 4 AuthorsPaul Poirier53
Estimated H-index: 53
(Laval University)
Abstract Objective To assess whether adding a video on atrial fibrillation (AF) to a face-to-face educational session improves quality of life (QoL), knowledge, and health resource utilization (HRU) among AF patients. Methods In this parallel clinical trial, adults with AF received a face-to-face educational session on AF and were randomly allocated to watch an educational video or not. Self-reported questionnaires measured QoL (primary outcome; score 0–100), AF knowledge (score 0–25), and HRU. ...
Published on Jun 11, 2019in British Journal of Nutrition 3.32
Dorothée Buteau-Poulin , Paul Poirier53
Estimated H-index: 53
+ 1 AuthorsNatalie Alméras39
Estimated H-index: 39
Haïfa Mahjoub9
Estimated H-index: 9
(Laval University),
Olivier Le Blanc3
Estimated H-index: 3
(Laval University)
+ -3 AuthorsPatrice Brassard18
Estimated H-index: 18
(Laval University)
High-intensity interval training (HIIT) improves physical performance of endurance athletes, although studies examining its cardiovascular effects are sparse. We evaluated the impact of HIIT on blo...
Published on Jun 1, 2019in The Lancet 59.10
Hertzel C. Gerstein89
Estimated H-index: 89
(Population Health Research Institute),
Helen M. Colhoun47
Estimated H-index: 47
(Edin.: University of Edinburgh)
+ 1453 AuthorsLars Rydén89
Estimated H-index: 89
(KI: Karolinska Institutet)
Summary Background Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the long-term effect of the GLP-1 receptor agonist dulaglutide on renal outcomes in an exploratory analysis of the REWIND trial of the effect of dulaglutide on cardiovascular disease. Methods REWIND was a multicentre, randomised, double-blind, placebo-controlled trial at 371 sites in 24 countries. Men and women aged at leas...
Marjorie Bastien7
Estimated H-index: 7
(Laval University),
Paul Poirier53
Estimated H-index: 53
(Laval University)
+ 5 AuthorsMarie-Ève Piché15
Estimated H-index: 15
(Laval University)
Targeting metabolic determinants of exercise performance with pharmacological agents that would mimic/potentiate the effects of exercise represents an attractive clinical alternative to counterbala...
Published on Jun 1, 2019in The Lancet 59.10
Hertzel C. Gerstein89
Estimated H-index: 89
(Population Health Research Institute),
Helen M. Colhoun47
Estimated H-index: 47
(Edin.: University of Edinburgh)
+ 1453 AuthorsLars Rydén89
Estimated H-index: 89
(KI: Karolinska Institutet)
Summary Background Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk with high glycated haemoglobin A 1c (HbA 1c ) concentrations. We assessed the effect of the GLP-1 receptor agonist dulaglutide on major adverse cardiovascular events when added to the existing antihyperglycaemic regimens of individuals with type 2 diabetes with and without previous cardiovascular disease and a wide range of...
Published on Jun 1, 2019in The Lancet Global Health 15.87
Anders H. Rosengren84
Estimated H-index: 84
(Sahlgrenska University Hospital),
Andrew Smyth17
Estimated H-index: 17
(National University of Ireland, Galway)
+ 38 AuthorsSadi Gulec18
Estimated H-index: 18
(Ankara University)
BACKGROUND:Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status-wealth and education-differ among high-income, middle-income, and low-income countries, and, if so, why these differences exist. We explored the association between education and household wealth and cardiovascular disease and...
12345678910